WCIT 2017平行會議(09/11、09/13)

August 17th, 2017 | Categories: 2017, 其他廣宣 | Tags:

Global Digital Health Forum:

The Precision Medicine & A.I. Revolution

 

According to IBM, it 2.5 quintillion bytes of data is generated every day, and 90% of the data currently available in the world was generated in the last two years alone. The American Recovery and Reinvestment Act of 2009 and the Precision Medicine Initiative of 2015 have endorsed the value of medical data. Since 80% of medical data is unstructured, artificial intelligence (A.I.) can help to generate insights from large volumes of data.  A.I. has become disruptive Innovations in biomedical sciences, and has great  impacts on pharmaceutical & biotech industries.  Building on the foundation of Taiwan’s  successful ICT industry, Taiwan government is  turning its sights toward the biomedical industry.  Therefore, the Development Center for Biotechnology (DCB) will organize this event to invite leading A.I. & biomedical experts  to share their insights.

 

數位醫療國際論壇

精準醫療新契機  AI革命大未來

 

從診斷到追蹤、從風險預測到個人化治療,精準醫療引爆全新應用與商業模式!

 

從影音辨識到疾病預測、從生物標記篩選到新藥開發,AI技術將掀起全球數位醫療革命!

 

2016年人類社會進入了人工智慧元年,IBM的預估指出,人類社會產生的數據量以每天以每天2.5 quintillion 位元組速度進行成長,且90%是在過去兩年內產生。

 

美國政府2009的國家投資計畫、2015年啟動的精準醫療計畫( Precision Medicine Initiative)都特別強調生醫領域的資料運用,也推動了美國大數據技術在應用的蓬勃發展。有鑑於 80%生醫領域資料是都是未結構化資料,因此人工智慧(artificial intelligence, A.I.) 演算法再生醫領域的應用能加速新藥與疾病治療方法的出現,因此A.I.這股破壞性創新力量,將對全球生技與醫療產業帶來巨大衝擊。

 

台灣過去成功的ICT領域已為台灣的資訊社會奠下良好的技術基礎,政府近年來更積極推動生醫產業的發展,希望善用台灣的科技基礎,掌握全球生醫商機。因此財團法人生物技術開發中心(DCB)在經濟部技術處之支持下,也希望藉由世界資訊科技大會(WCIT 2017)在台舉辦、兩千五百位國際貴賓來台之難得機會,邀請國際精準醫療與人工智慧專家來台進行洞見與經驗分享,藉此展現生技中心掌握生醫領域全球發展趨勢與前瞻藥物研發之能量。

 

 

 

Global Digital Health Forum:

The Precision Medicine & A.I. Revolution: Part 1

 

 

Time: 9/11/2017 (Monday)

Venue: Taipei International Convention Center (TICC) 3FL. North Lounge

Attendees: 50-60 senior executives from biomed and healthcare industries

A WCIT2017 Parallel Event

14:00 – 14:05

Welcome & Opening Remarks主辦單位致詞

 

Dr. Herbert Wu, President, the Development Center for Biotechnology

財團法人生物技術開發中心執行長吳忠勳博士

14:05 – 14:10

Guest of Honor Remarks貴賓致詞

 

Dr. Ta-Sheng, Lo. Acting General Director. Department of Industrial Technology, Ministry of Economic Affairs

經濟部技術處羅達生處長(TBC)

14:10 – 14:40

The Precision Medicine Era Powered by Big Data大數據驅動的精準醫療時代

 

Professor Yun Yen, President and Chair Professor, Taipei Medical University

台北醫學大學校長閻雲教授(TBC)

14:40 – 15:20

The Trends, Challenges and Opportunities of Precision Medicine精準醫療大趨勢

 

Ms. Rhenu Bhuller, Senior Vice President of Healthcare, Frost & Sullivan

弗若斯特和沙利文市場研究顧問公司醫療業資深副總瑞努·布勒女士

15:20 – 15:40

Coffee Break

15:40 – 16:20

Next-Gen Immunotherapeutics: from Conception to Clinical Reality in Cancer 次世代免疫療法

 

Dr. Chien-Tsun Kuan, Deputy Executive Director, Institute of Biologics, Development Center for Biotechnology

財團法人生物技術開發中心生物製藥研究所官建村副所長

16:20 – 17:00

The Potentials of Companion Diagnostics in Precision Medicine 精準醫療伴同式診斷之潛力           

 

Dr. Jia-Ming Chang, Executive Director, Institute of Pharmacology & Drug Disposition, Development Center for Biotechnology

財團法人生物技術開發中心平台技術研究所張嘉銘所長

17:00 – 17:30

Precision Medicine: Challenges & Opportunities 精準醫療:挑戰與契機         

 

Dr. Herbert Wu, President, the Development Center for Biotechnology

財團法人生物技術開發中心執行長吳忠勳博士

 

 

Global Digital Health Forum:

The Precision Medicine & A.I. Revolution: Part 2

 

Time: 9/13/2017 (Wednesday)

Venue: Taipei International Convention Center (TICC) , Room 102

Attendees: 200 senior executives from ICT, biomed and healthcare industries

A WCIT2017 Parallel Event

14:00 – 14:05

Welcome & Opening Remarks主辦單位致詞

 

Dr. Herbert Wu, President, Development Center for Biotechnology

財團法人生物技術開發中心執行長吳忠勳博士

Chin-Ho Hsieh, Publisher, Business Today Weekly

今周刊謝金河社長(TBC)

14:05 – 14:10

Guest of Honor Remarks貴賓致詞

 

Dr. Ta-Sheng, Lo. Acting General Director. Department of Industrial Technology, Ministry of Economic Affairs

經濟部技術處羅達生處長(TBC)

14:10 – 14:50

How Deep Learning Can Improve the Diagnosis and Treatment of Diseases 如何利用深度學習幫助疾病診斷及治療

 

Dr. Synho Do, Assistant Medical Director, Massachusetts General Hospital and Harvard Medical School

麻省總醫院及哈佛醫學院助理醫療主任都申浩博士

14:50 – 15:30

Applying Deep Adversarial Autoencoders for New Molecule Development in Oncology 利用深度對抗自動編碼器進行腫瘤新穎藥物開發

 

Artur Kadurin, Chief AI Officer, Insilico Medicine

Insilico Medicine首席AI長阿圖爾·卡杜林

15:30 – 16:10

A Paradigm Shift in Healthcare Created by AI 人工智慧啟動的醫療產業典範移轉

 

Dr. Samantha Huang, Director General, Division of Industrial Development, Development Center for Biotechnology

財團法人生物技術開發中心產業發展處處長黃玉華博士

16:10 – 16:30

Coffee Break

16:30 – 17:30

Panel Discussion

Moderator: Dr. Martin Hiesboeck, Digital Marketing Director, Geber Brand Consulting

格博品牌行銷顧問有限公司數位行銷總監/前奧地利駐台商務副代表解聰文博士

 

Panelists:

-        Dr. Synho Do, MGH & HMS

-        Artur Kadurin, Insilico Medicine

-        Dr. Samantha Huang, DCB

|

Referrer Plugin made by Electric Guitars.